Extrawell Pharmaceutical Holdings Limited (HKG:0858)
Hong Kong · Delayed Price · Currency is HKD 0.0800
+0.0100 (14.29%)
Jul 13, 2026, 3:35 PM HKT
HKG:0858 Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 51.48 | 55.43 | 59.1 | 72.58 | 73.93 | |
Revenue Growth (YoY) | -7.12% | -6.21% | -18.57% | -1.82% | -6.19% |
Cost of Revenue | 28.73 | 33.56 | 30.32 | 41.43 | 36.37 |
Gross Profit | 22.75 | 21.87 | 28.78 | 31.14 | 37.56 |
Selling, General & Admin | 32.75 | 30.9 | 35.25 | 42.42 | 50.5 |
Operating Expenses | 32.75 | 30.9 | 35.25 | 42.42 | 50.5 |
Operating Income | -10 | -9.03 | -6.47 | -11.28 | -12.94 |
Interest Expense | -26.13 | -22.11 | -18.8 | -15.64 | -13.23 |
Interest & Investment Income | 4.1 | 4.98 | 5.67 | 2.99 | 1.08 |
Earnings From Equity Investments | -3.43 | -2.31 | -2.28 | -3.85 | -3.65 |
Other Non Operating Income (Expenses) | -137.28 | -1.84 | -4.74 | -0.27 | -7.76 |
EBT Excluding Unusual Items | -172.75 | -30.31 | -26.61 | -28.05 | -36.5 |
Gain (Loss) on Sale of Investments | -813.59 | 254.9 | -132.93 | 158.66 | 168.64 |
Gain (Loss) on Sale of Assets | 0.11 | 0.01 | - | - | -0.06 |
Other Unusual Items | - | 0.12 | 0.12 | 0.28 | 0.25 |
Pretax Income | -986.23 | 224.72 | -159.42 | 130.9 | 132.33 |
Income Tax Expense | -8.44 | 1.17 | 2.13 | 1.13 | 1.24 |
Earnings From Continuing Operations | -977.79 | 223.55 | -161.56 | 129.77 | 131.09 |
Earnings From Discontinued Operations | - | -0.11 | -0.09 | - | - |
Net Income to Company | -977.79 | 223.45 | -161.64 | 129.77 | 131.09 |
Minority Interest in Earnings | -1.92 | -0.8 | -1.31 | -0.51 | -0.5 |
Net Income | -979.71 | 222.64 | -162.95 | 129.27 | 130.59 |
Net Income to Common | -979.71 | 222.64 | -162.95 | 129.27 | 130.59 |
Net Income Growth | - | - | - | -1.01% | - |
Shares Outstanding (Basic) | 2,479 | 2,390 | 2,390 | 2,390 | 2,390 |
Shares Outstanding (Diluted) | 2,479 | 3,290 | 2,390 | 3,290 | 3,290 |
Shares Change (YoY) | -24.65% | 37.66% | -27.36% | - | 37.66% |
EPS (Basic) | -0.40 | 0.09 | -0.07 | 0.05 | 0.05 |
EPS (Diluted) | -0.40 | 0.07 | -0.07 | 0.04 | 0.04 |
EPS Growth | - | - | - | 0.78% | - |
Free Cash Flow | - | -7.44 | -4.89 | -5.44 | -11.39 |
Free Cash Flow Per Share | - | -0.00 | -0.00 | -0.00 | -0.00 |
Gross Margin | 44.19% | 39.46% | 48.70% | 42.91% | 50.80% |
Operating Margin | -19.43% | -16.29% | -10.95% | -15.54% | -17.51% |
Profit Margin | -1903.05% | 401.67% | -275.73% | 178.11% | 176.65% |
Free Cash Flow Margin | - | -13.42% | -8.28% | -7.49% | -15.41% |
EBITDA | -3.45 | -2.47 | 0.82 | -4.63 | -6.4 |
EBITDA Margin | -6.69% | -4.46% | 1.38% | -6.38% | -8.66% |
D&A For EBITDA | 6.56 | 6.56 | 7.29 | 6.65 | 6.54 |
EBIT | -10 | -9.03 | -6.47 | -11.28 | -12.94 |
EBIT Margin | -19.43% | -16.29% | -10.95% | -15.54% | -17.51% |
Effective Tax Rate | - | 0.52% | - | 0.86% | 0.94% |